| TOP2B |
IPI00217709 |
RPS6KA2 |
RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 |
3.34 |
Evidence |
|
| MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
STAP2 |
Uncharacterized protein ENSP00000317912 |
3.34 |
Evidence |
|
| MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
C9orf88 |
IPI00647286 |
3.34 |
Evidence |
|
| MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
PKP4 |
PKP4: Plakophilin-4 |
3.34 |
Evidence |
|
| PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
SLC9A3R2 |
SLC9A3R2: SLC9A3R2 protein (Fragment) |
3.34 |
Evidence |
|
| PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
TRIM39 |
TRIM39, RNF23, TFP: Tripartite motif-containing protein 39 |
3.34 |
Evidence |
|
| PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
RAVER1 |
RAVER1, KIAA1978: Ribonucleoprotein PTB-binding 1 |
3.34 |
Evidence |
|
| H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
JDP2 |
jdp2, JDP2: Jun dimerization protein 2 |
3.34 |
Evidence |
|
| H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
AR |
AR, DHTR, NR3C4: Androgen receptor |
3.34 |
Evidence |
|
| H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
IRF7 |
IPI00298041 |
3.34 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
JDP2 |
jdp2, JDP2: Jun dimerization protein 2 |
3.34 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
AR |
AR, DHTR, NR3C4: Androgen receptor |
3.34 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
NFIA |
NFIA, RP5-902P15.1-003, hCG_2032260: Nuclear factor I/A |
3.34 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
IRF7 |
IPI00298041 |
3.34 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
DYRK1A |
DYRK1A, DYRK, MNB, MNBH: Dual specificity tyrosine-phosphorylation-regulated kin |
3.34 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
NFATC2 |
NFATC2, NFAT1, NFATP: Nuclear factor of activated T-cells, cytoplasmic 2 |
3.34 |
Evidence |
|
| EIF4G2 |
EIF4G2, DAP5, OK/SW-cl.75: Eukaryotic translation initiation factor 4 gamma 2 |
ZCCHC3 |
ZCCHC3, C20orf99: Zinc finger CCHC domain-containing protein 3 |
3.34 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
CAMKK1 |
IPI00166909 |
3.34 |
Evidence |
|
| CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
DYRK1A |
DYRK1A, DYRK, MNB, MNBH: Dual specificity tyrosine-phosphorylation-regulated kin |
3.34 |
Evidence |
|
| YWHAG |
YWHAG: 14-3-3 protein gamma |
GIT2 |
IPI00238218 |
3.34 |
Evidence |
|
| YWHAG |
YWHAG: 14-3-3 protein gamma |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
3.34 |
Evidence |
|
| HNRPK |
HNRPK, HNRNPK: Heterogeneous nuclear ribonucleoprotein K |
HSP90AA1 |
Hsp89-alpha-delta-N |
3.34 |
Evidence |
|
| RHOA |
RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
3.34 |
Evidence |
|
| RHOA |
RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
3.34 |
Evidence |
|
| CDC42 |
IPI00016786 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
3.34 |
Evidence |
|